drugset / Trial / NCT01908296

Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male Volunteers

NCT01908296

Phase 1 Completed 24 enrolled Astellas Pharma Inc
NaSingle-groupOpen-labelOther

Summary

The objective of the study was to assess the effect of multiple-dose fluvoxamine on the pharmacokinetics of quetiapine (FK949E) in healthy adult male subjects. The safety of FK949E in the population was also evaluated.

Timeline

Start
2011-07
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluvoxamine Unknown Oral
Subject Quetiapine Small molecule Oral

Indications

No indication recorded.